Early short course of neuromuscular blocking agents in patients with COVID-19 ARDS: a propensity score analysis

Early short course of neuromuscular blocking agents in patients with COVID-19 ARDS: a propensity score analysis

<strong>Background<br></strong> The role of neuromuscular blocking agents (NMBAs) in coronavirus disease 2019 (COVID-19) acute respiratory distress syndrome (ARDS) is not fully elucidated. Therefore, we aimed to investigate in COVID-19 patients with moderate-to-severe ARDS the impa...

Full description

Bibliographic Details
Main Authors: Li Bassi, G, Gibbons, K, Suen, JY, Dalton, HJ, White, N, Corley, A, Shrapnel, S, Hinton, S, Forsyth, S, Laffey, JG, Fan, E, Fanning, JP, Panigada, M, Bartlett, R, Brodie, D, Burrell, A, Chiumello, D, Elhazmi, A, Esperatti, M, Grasselli, G, Hodgson, C, Ichiba, S, Luna, C, Marwali, E, Merson, L, Murthy, S, Nichol, A, Ogino, M, Pelosi, P, Torres, A, Ng, PY, Fraser, JF
Other Authors: COVID-19 Critical Care Consortium
Format: Journal article
Language:English
Published: BioMed Central 2022

Similar Items

Similar Items